Royal Bank of Canada Cuts Stock Holdings in HealthEquity, Inc. $HQY

Royal Bank of Canada lessened its stake in HealthEquity, Inc. (NASDAQ:HQY) by 11.7% during the first quarter, Holdings Channel reports. The firm owned 299,007 shares of the company’s stock after selling 39,458 shares during the period. Royal Bank of Canada’s holdings in HealthEquity were worth $24,988,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Acumen Wealth Advisors LLC acquired a new stake in shares of HealthEquity during the 4th quarter worth $27,000. Aster Capital Management DIFC Ltd acquired a new position in HealthEquity in the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd boosted its holdings in HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares during the last quarter. Leonteq Securities AG grew its position in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the period. Finally, Torren Management LLC acquired a new stake in HealthEquity during the fourth quarter worth about $40,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $104.97 on Wednesday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96. The business has a 50 day moving average price of $92.42 and a two-hundred day moving average price of $85.41. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.78 billion, a PE ratio of 39.31, a price-to-earnings-growth ratio of 1.75 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 2,354 shares of HealthEquity stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on HQY shares. Citizens Jmp boosted their target price on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $85.00 to $105.00 in a research report on Thursday, April 9th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, July 25th. Finally, Royal Bank Of Canada raised their price objective on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. Eleven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.